RecruitingPhase 2NCT06222723

LAssa Fever Adjunct Treatment With DEXamethasone

Studying Lassa fever

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bernhard Nocht Institute for Tropical Medicine
Principal Investigator: Stephan Günther, Prof.
Bernhard Nocht Institute for Tropical Medicine
Intervention: Dexamethasone(drug)
Enrollment: 42 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2026

Study locations (1)

Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06222723 on ClinicalTrials.gov

Other trials for Lassa fever

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07419373
ARN-75039 Lassa Fever Treatment in West Africa
Arisan Therapeutics, Inc.
RECRUITINGPHASE2, PHASE3NCT06212336
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Irrua Specialist Teaching Hospital
ACTIVE NOT RECRUITINGPHASE1NCT06546709
DMID 23-0015; Lassa Fever CVD 1000
Wilbur Chen, MD, MS
RECRUITINGPHASE2NCT05868733
A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
International AIDS Vaccine Initiative
ACTIVE NOT RECRUITINGNCT03655561
Lassa Fever Clinical Course and Prognostic Factors in Nigeria
Alliance for International Medical Action

See all trials for Lassa fever →

← Back to all trials